Published :
Tables : 64
Figures : 44
Category : Healthcare
No. of Pages : 215
Report Code : HC-U3147
Immunoassay Market is poised to value over USD 27 billion by 2027 end with a CAGR of over 5.8% during the forecast period 2020 to 2027. The growth in the number of infectious and chronic disease cases, increased awareness among patients pertaining to immunoassays, technological advancements in immunoassay products are some of the important factors responsible for the proliferation of the market. FutureWise Market Research has instantiated a report that provides an intricate analysis of Immunoassay Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of Immunoassay Market. According to the research study conducted by FutureWise research analysts, the Immunoassay Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Immunoassay Market are: Roche Abbott Laboratories Siemens Danaher Diasorin Sysmex Biomérieux Ortho Clinical Diagnostics Qiagen Thermo Fisher Scientific Becton, Dickinson & Company Bio-Rad Laboratories Agilent Technologies Mindray Perkinelmer (Note: The list of the major players will be updated with the latest market scenario and trends) Immunoassay Market Segmentation: By Product & Service Reagents & Kits o Enzyme-linked Immunosorbent Assay (ELISA) Reagents and Kits o Rapid Test Reagents and Kits o Enzyme-linked immunospot ELISPOT Reagents and Kits o Western Blot Reagents and Kits o Other Reagents & Kits Analyzers o By Type o Open-ended Systems o Closed-ended systems o By Purchase Mode o Rental Purchase o Outright Purchase Software & Services By Platform Chemiluminescence Immunoassays (CLIAs) Fluorescence Immunoassays (FIAs) Colorimetric Immunoassays (CIs) Radioimmunoassays (RIAs) Other Platforms By Technology ELISA First-generation Second-generation Third-generation Fourth-generation & Above Rapid Tests Western Blotting ELISPOT Immuno-PCR Other Technologies By Specimen Blood Saliva Urine Other Specimens By Application Infectious Diseases Endocrinology Oncology Bone & Mineral Disorders Cardiology Hematology & Blood Screening Autoimmune Disorders Toxicology Neonatal Screening Other Applications By End User Hospitals Clinical Laboratories Pharmaceutical and Biotechnology Companies & Contract Research Organizations (CROs) Blood Banks Research & Academic Laboratories Other End Users By Region North America Latin America Europe Asia-Pacific Rest of the world Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting the market growth Objectives of the Study: To provide with an exhaustive analysis on the Immunoassay Market By Product & Service, By Platform, By Technology, By Specimen, By Application, By End User and By Region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with the purchase of any license of the report You can directly share your requirements/changes to the current table of content to sales@futurewiseresearch.com
The growth in the number of infectious and chronic disease cases, increased awareness among patients pertaining to immunoassays, technological advancements in immunoassay products are some of the important factors responsible for the proliferation of the market.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Immunoassay Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of Immunoassay Market.
According to the research study conducted by FutureWise research analysts, the Immunoassay Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Immunoassay Market are:
(Note: The list of the major players will be updated with the latest market scenario and trends)
Immunoassay Market Segmentation:
By Product & Service
By Platform
By Technology
By Specimen
By Application
By End User
By Region
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Immunoassay Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Biotech Companies Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of CNNs 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Immunoassay Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. By Product & Service Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Reagents & Kits 7.1.1. Enzyme-linked Immunosorbent Assay (ELISA) Reagents and Kits 7.1.2. Rapid Test Reagents and Kits 7.1.3. Enzyme-linked immunospot ELISPOT Reagents and Kits 7.1.4. Western Blot Reagents and Kits 7.1.5. Other Reagents & Kits 7.2. Analyzers 7.2.1. By Type 7.2.1.1. Open-ended Systems 7.2.1.2. Closed-ended systems 7.2.2. By Purchase Mode 7.2.2.1. Rental Purchase 7.2.2.2. Outright Purchase 7.3. Software & Services 8. By Platform Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Chemiluminescence Immunoassays (CLIAs) 8.2. Fluorescence Immunoassays (FIAs) 8.3. Colorimetric Immunoassays (CIs) 8.4. Radioimmunoassays (RIAs) 8.5. Other Platforms 9. By Technology Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. ELISA 9.1.1. First-generation 9.1.2. Second-generation 9.1.3. Third-generation 9.1.4. Fourth-generation & Above 9.2. Rapid Tests 9.3. Western Blotting 9.4. ELISPOT 9.5. Immuno-PCR 9.6. Other Technologies 10. By Specimen Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Blood 10.2. Saliva 10.3. Urine 10.4. Other Specimens 11. By Application Historical Analysis and Forecast 2020-2027 (USD Million) 11.1. Infectious Diseases 11.2. Endocrinology 11.3. Oncology 11.4. Bone & Mineral Disorders 11.5. Cardiology 11.6. Haematology & Blood Screening 11.7. Autoimmune Disorders 11.8. Toxicology 11.9. Neonatal Screening 11.10. Other Applications 12. By End User Historical Analysis and Forecast 2020-2027 (USD Million) 12.1. Hospitals 12.2. Clinical Laboratories 12.3. Pharmaceutical and Biotechnology Companies & Contract Research Organizations (CROs) 12.4. Blood Banks 12.5. Research & Academic Laboratories 12.6. Other End Users 13. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. U.S.A 13.2.2. Canada 13.2.3. Mexico 13.3. Market Size (USD Million) Forecast for North America 2020-2027 14. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Regional Market Trends 14.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.3.1. Brazil 14.3.2. Venezuela 14.3.3. Argentina 14.3.4. Rest of Latin America 14.4. Market Size (USD Million) Forecast for Latin America 2020-2027 15. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Germany 15.2.2. U.K 15.2.3. France 15.2.4. Italy 15.2.5. Spain 15.2.6. Russia 15.2.7. Poland 15.2.8. Switzerland 15.2.9. Romania 15.2.10. Rest of Western Europe 15.3. Market Size (USD Million) Forecast for Europe 2020-2027 16. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 16.2.1. Japan 16.2.2. China 16.2.3. Singapore 16.2.4. India 16.2.5. Australia and New Zealand 16.2.6. ASEAN 16.2.7. South Korea 16.2.8. Rest of Asia Pacific 16.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 17. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 17.2.1. Saudi Arabia 17.2.2. UAE 17.2.3. South Africa 17.2.4. Egypt 17.3. Market Size (USD Million) Forecast for MEA 2020-2027 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 18.1 Roche 18.1.1 Company Overview 18.1.2 Financial Overview 18.1.3 Strategic Overview 18.1.4 Product Portfolio 18.1.5 SWOT Analysis 18.2 Abbott Laboratories 18.2.1 Company Overview 18.2.2 Financial Overview 18.2.3 Strategic Overview 18.2.4 Product Portfolio 18.2.5 SWOT Analysis 18.3 Siemens 18.3.1 Company Overview 18.3.2 Financial Overview 18.3.3 Strategic Overview 18.3.4 Product Portfolio 18.3.5 SWOT Analysis 18.4. Danaher 18.4.1 Company Overview 18.4.2 Financial Overview 18.4.3 Strategic Overview 18.4.4 Product Portfolio 18.4.5 SWOT Analysis 18.5. Diasorin 18.5.1 Company Overview 18.5.2 Financial Overview 18.5.3 Strategic Overview 18.5.4 Product Portfolio 18.5.5 SWOT Analysis 18.6. Sysmex 18.6.1 Company Overview 18.6.2 Financial Overview 18.6.3 Strategic Overview 18.6.4 Product Portfolio 18.6.5 SWOT Analysis 18.7. Biomérieux 18.7.1 Company Overview 18.7.2 Financial Overview 18.7.3 Strategic Overview 18.7.4 Product Portfolio 18.7.5 SWOT Analysis 18.8. Ortho Clinical Diagnostics 18.8.1 Company Overview 18.8.2 Financial Overview 18.8.3 Strategic Overview 18.8.4 Product Portfolio 18.8.5 SWOT Analysis 18.9. Qiagen 18.9.1 Company Overview 18.9.2 Financial Overview 18.9.3 Strategic Overview 18.9.4 Product Portfolio 18.9.5 SWOT Analysis 18.10. Thermo Fisher Scientific 18.10.1 Company Overview 18.10.2 Financial Overview 18.10.3 Strategic Overview 18.10.4 Product Portfolio 18.10.5 SWOT Analysis 18.11. Becton, Dickinson & Company 18.11.1 Company Overview 18.11.2 Financial Overview 18.11.3 Strategic Overview 18.11.4 Product Portfolio 18.11.5 SWOT Analysis 18.12. Bio-Rad Laboratories 18.12.1 Company Overview 18.12.2 Financial Overview 18.12.3 Strategic Overview 18.12.4 Product Portfolio 18.12.5 SWOT Analysis 18.13. Agilent Technologies 18.13.1 Company Overview 18.13.2 Financial Overview 18.13.3 Strategic Overview 18.13.4 Product Portfolio 18.13.5 SWOT Analysis 18.14. Mindray 18.14.1 Company Overview 18.14.2 Financial Overview 18.14.3 Strategic Overview 18.14.4 Product Portfolio 18.14.5 SWOT Analysis 18.15 Perkinelmer 18.15.1 Company Overview 18.15.2 Financial Overview 18.15.3 Strategic Overview 18.15.4 Product Portfolio 18.15.5 SWOT Analysis 19. FutureWise SME key takeaway points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary
3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Global Immunoassay Market Variables, Trends & Scope
4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Biotech Companies Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of CNNs 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Immunoassay Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. By Product & Service Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Reagents & Kits 7.1.1. Enzyme-linked Immunosorbent Assay (ELISA) Reagents and Kits 7.1.2. Rapid Test Reagents and Kits 7.1.3. Enzyme-linked immunospot ELISPOT Reagents and Kits 7.1.4. Western Blot Reagents and Kits 7.1.5. Other Reagents & Kits 7.2. Analyzers 7.2.1. By Type 7.2.1.1. Open-ended Systems 7.2.1.2. Closed-ended systems 7.2.2. By Purchase Mode 7.2.2.1. Rental Purchase 7.2.2.2. Outright Purchase 7.3. Software & Services
8. By Platform Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Chemiluminescence Immunoassays (CLIAs) 8.2. Fluorescence Immunoassays (FIAs) 8.3. Colorimetric Immunoassays (CIs) 8.4. Radioimmunoassays (RIAs) 8.5. Other Platforms
9. By Technology Historical Analysis and Forecast 2020-2027 (USD Million)
9.1. ELISA 9.1.1. First-generation 9.1.2. Second-generation 9.1.3. Third-generation 9.1.4. Fourth-generation & Above 9.2. Rapid Tests 9.3. Western Blotting 9.4. ELISPOT 9.5. Immuno-PCR 9.6. Other Technologies
10. By Specimen Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Blood 10.2. Saliva 10.3. Urine 10.4. Other Specimens
11. By Application Historical Analysis and Forecast 2020-2027 (USD Million) 11.1. Infectious Diseases 11.2. Endocrinology 11.3. Oncology 11.4. Bone & Mineral Disorders 11.5. Cardiology 11.6. Haematology & Blood Screening 11.7. Autoimmune Disorders 11.8. Toxicology 11.9. Neonatal Screening 11.10. Other Applications
12. By End User Historical Analysis and Forecast 2020-2027 (USD Million) 12.1. Hospitals 12.2. Clinical Laboratories 12.3. Pharmaceutical and Biotechnology Companies & Contract Research Organizations (CROs) 12.4. Blood Banks 12.5. Research & Academic Laboratories 12.6. Other End Users
13. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. U.S.A 13.2.2. Canada 13.2.3. Mexico 13.3. Market Size (USD Million) Forecast for North America 2020-2027
14. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Regional Market Trends 14.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.3.1. Brazil 14.3.2. Venezuela 14.3.3. Argentina 14.3.4. Rest of Latin America 14.4. Market Size (USD Million) Forecast for Latin America 2020-2027
15. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Germany 15.2.2. U.K 15.2.3. France 15.2.4. Italy 15.2.5. Spain 15.2.6. Russia 15.2.7. Poland 15.2.8. Switzerland 15.2.9. Romania 15.2.10. Rest of Western Europe 15.3. Market Size (USD Million) Forecast for Europe 2020-2027 16. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 16.2.1. Japan 16.2.2. China 16.2.3. Singapore 16.2.4. India 16.2.5. Australia and New Zealand 16.2.6. ASEAN 16.2.7. South Korea 16.2.8. Rest of Asia Pacific 16.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
17. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 17.2.1. Saudi Arabia 17.2.2. UAE 17.2.3. South Africa 17.2.4. Egypt 17.3. Market Size (USD Million) Forecast for MEA 2020-2027 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 18.1 Roche 18.1.1 Company Overview 18.1.2 Financial Overview 18.1.3 Strategic Overview 18.1.4 Product Portfolio 18.1.5 SWOT Analysis 18.2 Abbott Laboratories 18.2.1 Company Overview 18.2.2 Financial Overview 18.2.3 Strategic Overview 18.2.4 Product Portfolio 18.2.5 SWOT Analysis 18.3 Siemens 18.3.1 Company Overview 18.3.2 Financial Overview 18.3.3 Strategic Overview 18.3.4 Product Portfolio 18.3.5 SWOT Analysis 18.4. Danaher 18.4.1 Company Overview 18.4.2 Financial Overview 18.4.3 Strategic Overview 18.4.4 Product Portfolio 18.4.5 SWOT Analysis 18.5. Diasorin 18.5.1 Company Overview 18.5.2 Financial Overview 18.5.3 Strategic Overview 18.5.4 Product Portfolio 18.5.5 SWOT Analysis 18.6. Sysmex 18.6.1 Company Overview 18.6.2 Financial Overview 18.6.3 Strategic Overview 18.6.4 Product Portfolio 18.6.5 SWOT Analysis 18.7. Biomérieux 18.7.1 Company Overview 18.7.2 Financial Overview 18.7.3 Strategic Overview 18.7.4 Product Portfolio 18.7.5 SWOT Analysis 18.8. Ortho Clinical Diagnostics 18.8.1 Company Overview 18.8.2 Financial Overview 18.8.3 Strategic Overview 18.8.4 Product Portfolio 18.8.5 SWOT Analysis 18.9. Qiagen 18.9.1 Company Overview 18.9.2 Financial Overview 18.9.3 Strategic Overview 18.9.4 Product Portfolio 18.9.5 SWOT Analysis 18.10. Thermo Fisher Scientific 18.10.1 Company Overview 18.10.2 Financial Overview 18.10.3 Strategic Overview 18.10.4 Product Portfolio 18.10.5 SWOT Analysis 18.11. Becton, Dickinson & Company 18.11.1 Company Overview 18.11.2 Financial Overview 18.11.3 Strategic Overview 18.11.4 Product Portfolio 18.11.5 SWOT Analysis 18.12. Bio-Rad Laboratories 18.12.1 Company Overview 18.12.2 Financial Overview 18.12.3 Strategic Overview 18.12.4 Product Portfolio 18.12.5 SWOT Analysis 18.13. Agilent Technologies 18.13.1 Company Overview 18.13.2 Financial Overview 18.13.3 Strategic Overview 18.13.4 Product Portfolio 18.13.5 SWOT Analysis 18.14. Mindray 18.14.1 Company Overview 18.14.2 Financial Overview 18.14.3 Strategic Overview 18.14.4 Product Portfolio 18.14.5 SWOT Analysis 18.15 Perkinelmer 18.15.1 Company Overview 18.15.2 Financial Overview 18.15.3 Strategic Overview 18.15.4 Product Portfolio 18.15.5 SWOT Analysis
19. FutureWise SME key takeaway points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics